Kelly C Goldsmith, MD

Pediatric Hematologist/Oncologist

Gender

Female

Language

English

Dr. Goldsmith’s clinical and research interests are in high risk and recurrent solid tumors, specifically the pediatric solid tumor neuroblastoma. Her laboratory research expertise is in apoptosis deregulation in cancer, the Bcl-2 family, and novel immunotherapies for neuroblastoma. Her translational research provided the concept behind a first in pediatrics Phase I trial of simvastatin in combination with chemotherapy for recurrent solid/CNS tumors of childhood and helped support the Abbvie first in pediatrics trial of the Bcl-2 inhibitor Venetoclax. She is co-chair of a NANT Precision Medicine Study for recurrent neuroblastoma and the NANT Phase 1 study of the ALK inhibitor Lorlatinib for patients with ALK driven recurrent or refractory neuroblastoma. She also is co-chair of a Phase 2 study in the Children’ Oncology Group (COG) for patients with refractory neuroblastoma. Dr. Goldsmith rounds out her bench to bedside efforts as the Clinical Director of our Refractory and Recurrent Neuroblastoma Program and Aflac Precision Medicine Programs where she and her team work to match a relapsed patient with the appropriate targeted therapy for their recurrent disease.

Locations

Aflac Cancer and Blood Disorders Center

Egleston Hospital, 1405 Clifton Road NE
Atlanta, GA 30322
Get Directions 404-785-1112

Aflac Cancer and Blood Disorders Center

Scottish Rite hospital, 1001 Johnson Ferry Road NE
Atlanta, GA 30342
Get Directions 404-785-5252

Aflac Cancer and Blood Disorders Center

Health Sciences Research Building, 1760 Haygood Drive
Atlanta, GA 30322
Get Directions

Focus of Practice

  • Neuroblastoma, high risk and relapsed/refractory disease
  • Developmental Therapeutics and early phase clinical trials for pediatric solid tumors
  • Aflac Precision Medicine Program, Clinical Director - Tumor genetic sequencing to personalize therapy decision making for high risk pediatric cancers

Areas of Interest

  • Translational Laboratory research in Recurrent/Refractory Neuroblastoma
  • Clinical Research in Neuroblastoma, both locally and through COG and NANT
  • Novel Immunotherapy approaches in pediatric solid tumors

Professional Affiliations

  • American Association for Cancer Research
  • American Society of Clinical Oncology
  • Advances in Neuroblastoma Research Association
  • Children’s Oncology Group
  • Society for Pediatric Research
$( document ).ready(function() { addthis.init(); });